106 related articles for article (PubMed ID: 12838964)
1. Low dose, long-term warfarin safely prevents blood clots.
Levenson D
Rep Med Guidel Outcomes Res; 2003 Mar; 14(6):1-2. PubMed ID: 12838964
[No Abstract] [Full Text] [Related]
2. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
Tran H; McRae S; Ginsberg J
Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
[TBL] [Abstract][Full Text] [Related]
3. Taming killer clots.
Comarow A
US News World Rep; 2003 Mar; 134(7):56. PubMed ID: 12645476
[No Abstract] [Full Text] [Related]
4. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Malik V; Kupfer Y; Tessler S
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658127
[No Abstract] [Full Text] [Related]
5. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Brotman DJ
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658124
[No Abstract] [Full Text] [Related]
6. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Huisman MV; van der Meer FJ; van Rooden CJ; Prins MH
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14645647
[No Abstract] [Full Text] [Related]
7. On the alert for deep-vein blood clots. Clots that form in a leg or arm vein can be deadly; prevention is key.
Harv Heart Lett; 2009 May; 19(9):4-5. PubMed ID: 19691164
[No Abstract] [Full Text] [Related]
8. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Ridker PM; Goldhaber SZ; Glynn RJ
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658125
[No Abstract] [Full Text] [Related]
9. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Tran HA
N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658126
[No Abstract] [Full Text] [Related]
10. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
[TBL] [Abstract][Full Text] [Related]
11. [Early and loud].
Schellong S
Vasa; 2003 May; 32(2):59-60. PubMed ID: 12945096
[No Abstract] [Full Text] [Related]
12. [Malignancy and venous thromboembolism].
Madoiwa S
Rinsho Ketsueki; 2007 May; 48(5):371-6. PubMed ID: 17571581
[No Abstract] [Full Text] [Related]
13. Duration of warfarin in pulmonary embolism.
Miller A; Campbell I; Fennerty T; Raskob GE; Büller HR
Chest; 2006 Jul; 130(1):299; author reply 299-300. PubMed ID: 16840417
[No Abstract] [Full Text] [Related]
14. The treatment of deep venous thrombosis, including the newer agents.
Rectenwald JE; Wakefield TW
Dis Mon; 2005; 51(2-3):104-11. PubMed ID: 15900261
[No Abstract] [Full Text] [Related]
15. Advances in DVT prophylaxis and management in major orthopaedic surgery.
Hardwick ME; Colwell CW
Surg Technol Int; 2004; 12():265-8. PubMed ID: 15455336
[TBL] [Abstract][Full Text] [Related]
16. National Heart, Lung, and Blood Institute programs for deep vein thrombosis.
Link RP
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):392-3. PubMed ID: 18296595
[No Abstract] [Full Text] [Related]
17. Long term anticoagulation of idiopathic venous thromboembolism: do we have the answers?
Goldhaber S
Clin Adv Hematol Oncol; 2003 May; 1(5):276-7. PubMed ID: 16224420
[No Abstract] [Full Text] [Related]
18. [Update on current care guidelines. Deep thrombosis and pulmonary embolism].
Lassila R; Halinen M; Harjola VP; Kaaja R; Kunnamo I; Manninen H; Melin J; Mustonen P; Pohjola-Sintonen S; Puurunen M; Sinisalo J; Teittinen J
Duodecim; 2005; 121(9):1001-2. PubMed ID: 15991745
[No Abstract] [Full Text] [Related]
19. Ximelagatran for treatment and prophylaxis of recurrent events in deep vein thrombosis.
Koscielny J; Kiesewetter H; Jörg I; Harenberg J
Clin Appl Thromb Hemost; 2007 Jul; 13(3):299-307. PubMed ID: 17636192
[TBL] [Abstract][Full Text] [Related]
20. Long-term anticoagulation prophylaxis following acute thromboembolism.
Hyers TM
Dis Mon; 2005; 51(2-3):158-65. PubMed ID: 15900268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
